Skip to Content

ADCETRIS 50 mg powder for concentrate for solution for infusion

Licence status
Authorised: 25/10/2012
Active substances
Brentuximab vedotin
Dosage Form
Powder for concentrate for solution for infusion
Licence number
EU/1/12/794/001
Licence holder
Takeda Pharma A/S

Licence information

ATC code
L01FX05 brentuximab vedotin
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
25/10/2012